Current gross examination and reporting patterns of post–neoadjuvant chemotherapy cystectomy specimens

Online journal article in Surgical Pathology that offers 1.0 continuing education (CME) credit that can be used to fulfill CC Part II requirements.

Quantity:

Want to save more?

Log into see if you qualify for a lower rate.

Members

save $5.00 or more

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

Outline the published standard approach reported in the College of American Pathologists (CAP) Caner Protocols and in monographs from the Association of...

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

Outline the published standard approach reported in the College of American Pathologists (CAP) Caner Protocols and in monographs from the Association of Directors of Anatomic and Surgical Pathology (ADASP) regarding the macroscopic examination and sectioning protocol for radical cystectomy specimens not treated with neoadjuvant chemotherapy
Discuss current approaches to the macroscopic examination of cystectomy specimens following neoadjuvant chemotherapy (NAC) and the challenges encountered when there is no gross evidence of residual tumor.

List histological changes that can suggest prior biopsy site changes in cystectomy specimens after NAC

View More View Less